Radiation oncology in the era of precision medicine

M Baumann, M Krause, J Overgaard, J Debus… - Nature Reviews …, 2016 - nature.com
Technological advances and clinical research over the past few decades have given
radiation oncologists the capability to personalize treatments for accurate delivery of …

Exploring the role of cancer stem cells in radioresistance

M Baumann, M Krause, R Hill - Nature Reviews Cancer, 2008 - nature.com
Radiobiological research over the past decades has provided evidence that cancer stem
cell content and the intrinsic radiosensitivity of cancer stem cells varies between tumours …

Repopulation of cancer cells during therapy: an important cause of treatment failure

JJ Kim, IF Tannock - Nature Reviews Cancer, 2005 - nature.com
Radiotherapy and chemotherapy are given in multiple doses, which are spaced out to allow
the recovery of normal tissues between treatments. However, surviving cancer cells also …

Decision support systems for personalized and participative radiation oncology

P Lambin, J Zindler, BGL Vanneste… - Advanced drug delivery …, 2017 - Elsevier
A paradigm shift from current population based medicine to personalized and participative
medicine is underway. This transition is being supported by the development of clinical …

Modulation of the tumor vasculature and oxygenation to improve therapy

DW Siemann, MR Horsman - Pharmacology & therapeutics, 2015 - Elsevier
The tumor microenvironment is increasingly recognized as a major factor influencing the
success of therapeutic treatments and has become a key focus for cancer research. The …

Cancer biomarker discovery: current status and future perspectives

K Mäbert, M Cojoc, C Peitzsch, I Kurth… - … journal of radiation …, 2014 - Taylor & Francis
Purpose: Cancer is a multigene disease which arises as a result of mutational and
epigenetic changes coupled with activation of complex signaling networks. The use of …

ARCON: a novel biology-based approach in radiotherapy

JHAM Kaanders, J Bussink, AJ van der Kogel - The lancet oncology, 2002 - thelancet.com
Two mechanisms of radiotherapy resistance which are of major importance in various
tumour types are tumour-cell repopulation and hypoxia. ARCON (accelerated radiotherapy …

Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV (−) HNSCC after postoperative radiochemotherapy: a multicenter …

A Linge, S Löck, V Gudziol, A Nowak, F Lohaus… - Clinical cancer …, 2016 - AACR
Purpose: To investigate the impact of hypoxia-induced gene expression and cancer stem
cell (CSC) marker expression on outcome of postoperative cisplatin-based …

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 …

E Ben-Josef, J Moughan, JA Ajani, M Flam… - Journal of clinical …, 2010 - ascopubs.org
Purpose To determine whether increased duration of radiation therapy (RT) and overall
treatment (RX) time has a detrimental effect in anal cancer. Patients and Methods Data from …

18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors

EGC Troost, J Bussink, AL Hoffmann… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Accelerated tumor cell proliferation is an important mechanism adversely affecting
therapeutic outcome in head and neck cancer. 3′-deoxy-3′-18F-fluorothymidine (18F …